The federal government is clawing back $11.4 billion in COVID-19 funding, a move that could affect local and state public health efforts across the US.

The Senate has confirmed Dr Jay Bhattacharya as the new director of the NIH and Dr Marty Makary as the new commissioner of the FDA.

ICI-based combinations are the preferred first-line therapy due to their proven superiority over TKI monotherapy, many patients were not receiving them,” the researchers wrote.

(HealthDay News) — Grants from the National Institutes of Health (NIH) that were funding research on LGBTQ+ health have been canceled by the US government, alarming scientists who say the move will ...

Data suggest that SC pembrolizumab is non-inferior to IV pembrolizumab in patients with newly diagnosed, advanced NSCLC.

The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

Americans living in rural communities could see their access to health care diminish if Congress changes eligibility for Medicaid or significantly reduces funding.

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection) for use in patients with prostate cancer.

A fake web page designed to look like the CDC vaccine safety site has been taken down on orders from HHS secretary Robert F. Kennedy Jr.

Childhood cancer survivors “may experience considerable accelerated aging throughout their lifespan,” the researchers wrote.

Patients with MSI-H mCRC had a higher probability of survival with first-line ICI therapy than with chemotherapy, but second-line or later ICIs did not confer the same benefit.

Researchers proposed changing the recommendations for universal driving restrictions after CAR T-cell infusion.